col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


92 Results       Page 1

 [1] 
Springer Science and Business Media LLC: Nature Microbiology
  original article Date Title Authors   All Authors
1 [GO] 2024―Jul―12 A safe, effective and adaptable live-attenuated SARS-CoV-2 vaccine to reduce disease and transmission using one-to-stop genome modifications Jacob Schön, G. Tuba Barut, Bettina Salome Trüeb, Nico Joel Halwe, Inês Berenguer Veiga, Annika Kratzel, et al. (+32)
2 [GO] 2024―Jun―18 Author Correction: Age-specific nasal epithelial responses to SARS-CoV-2 infection Maximillian N. J. Woodall, Ana-Maria Cujba, Kaylee B. Worlock, Katie-Marie Case, Tereza Masonou, Masahiro Yoshida, et al. (+33)
3 [GO] 2024―Apr―22 Targeted accurate RNA consensus sequencing (tARC-seq) reveals mechanisms of replication error affecting SARS-CoV-2 divergence Catherine C. Bradley, Chen Wang, Alasdair J. E. Gordon, Alice X. Wen, Pamela N. Luna, Matthew B. Cooke, et al. (+8)
4 [GO] 2024―Apr―15 Age-specific nasal epithelial responses to SARS-CoV-2 infection Maximillian N. J. Woodall, Ana-Maria Cujba, Kaylee B. Worlock, Katie-Marie Case, Tereza Masonou, Masahiro Yoshida, et al. (+33)
5 [GO] 2024―Mar―29 Preclinical evaluation of the SARS-CoV-2 Mpro inhibitor RAY1216 shows improved pharmacokinetics compared with nirmatrelvir Xiaoxin Chen, Xiaodong Huang, Qinhai Ma, Petr Kuzmič, Biao Zhou, Sai Zhang, et al. (+27)
6 [GO] 2024―Mar―28 Brain exposure to SARS-CoV-2 virions perturbs synaptic homeostasis Emma Partiot, Aurélie Hirschler, Sophie Colomb, Willy Lutz, Tine Claeys, François Delalande, et al. (+15)
7 [GO] 2024―Jan―16 Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants Ann-Kathrin Reuschl, Lucy G. Thorne, Matthew V. X. Whelan, Roberta Ragazzini, Wilhelm Furnon, Vanessa M. Cowton, et al. (+10)
8 [GO] 2023―Nov―06 Immune imprinting and next-generation coronavirus vaccines Chloe Qingzhou Huang, Sneha Vishwanath, George William Carnell, Andrew Chun Yue Chan, Jonathan Luke Heeney
9 [GO] 2023―Oct―16 SARS-CoV-2 evolution in the Omicron era Cornelius Roemer, Daniel J. Sheward, Ryan Hisner, Federico Gueli, Hitoshi Sakaguchi, Nicholas Frohberg, et al. (+8)
10 [GO] 2023―Oct―05 Using autopsies to dissect COVID-19 pathogenesis Fabian Heinrich, Kirsten D. Mertz, Markus Glatzel, Martin Beer, Susanne Krasemann
11 [GO] 2023―Sep―25 Host range, transmissibility and antigenicity of a pangolin coronavirus Yixuan J. Hou, Shiho Chiba, Sarah R. Leist, Rita M. Meganck, David R. Martinez, Alexandra Schäfer, et al. (+19)
12 [GO] 2023―Sep―25 Zoonotic potential of a pangolin coronavirus Woo-Jin Shin, Seokmin Kang, Jae U. Jung
13 [GO] 2023―May―25 Coronavirus sampling and surveillance in bats from 1996-2019: a systematic review and meta-analysis Lily E. Cohen, Anna C. Fagre, Binqi Chen, Colin J. Carlson, Daniel J. Becker
14 [GO] 2023―May―04 Therapeutics for COVID-19 Sima S. Toussi, Jennifer L. Hammond, Brian S. Gerstenberger, Annaliesa S. Anderson
15 [GO] 2023―Apr―03 Fc-γR-dependent antibody effector functions are required for vaccine-mediated protection against antigen-shifted variants of SARS-CoV-2 Samantha R. Mackin, Pritesh Desai, Bradley M. Whitener, Courtney E. Karl, Meizi Liu, Ralph S. Baric, et al. (+5)
16 [GO] 2023―Apr―03 Live-attenuated vaccine sCPD9 elicits superior mucosal and systemic immunity to SARS-CoV-2 variants in hamsters Geraldine Nouailles, Julia M. Adler, Peter Pennitz, Stefan Peidli, Luiz Gustavo Teixeira Alves, Morris Baumgardt, et al. (+29)
17 [GO] 2023―Mar―23 SARS-CoV-2 restructures host chromatin architecture Ruoyu Wang, Joo-Hyung Lee, Jieun Kim, Feng Xiong, Lana Al Hasani, Yuqiang Shi, et al. (+10)
18 [GO] 2023―Jan―19 Author Correction: Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile Mónica L. Acevedo, Aracelly Gaete-Argel, Luis Alonso-Palomares, Marco Montes de Oca, Andrés Bustamante, Aldo Gaggero, et al. (+10)
19 [GO] 2023―Jan―05 Fluorogenic reporter enables identification of compounds that inhibit SARS-CoV-2 Junjiao Yang, Yinghong Xiao, Peter V. Lidsky, Chien-Ting Wu, Luke R. Bonser, Shiming Peng, et al. (+14)
20 [GO] 2023―Jan―02 Comparative effectiveness of third doses of mRNA-based COVID-19 vaccines in US veterans Barbra A. Dickerman, Hanna Gerlovin, Arin L. Madenci, Michael J. Figueroa Muñiz, Jessica K. Wise, Nimish Adhikari, et al. (+6)
21 [GO] 2022―Dec―22 SARS-CoV-2 Africa dashboard for real-time COVID-19 information Joicymara S. Xavier, Monika Moir, Houriiyah Tegally, Nikita Sitharam, Wasim Abdool Karim, James E. San, et al. (+6)
22 [GO] 2022―Dec―12 Publisher Correction: Divergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission Bradley Pickering, Oliver Lung, Finlay Maguire, Peter Kruczkiewicz, Jonathon D. Kotwa, Tore Buchanan, et al. (+34)
23 [GO] 2022―Nov―14 Safety and immunogenicity of a prefusion non-stabilized spike protein mRNA COVID-19 vaccine: a phase I trial Sivaporn Gatechompol, Wonngarm Kittanamongkolchai, Chutitorn Ketloy, Eakchai Prompetchara, Arunee Thitithanyanont, Anan Jongkaewwattana, et al. (+17)
24 [GO] 2022―Nov―10 Divergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission Bradley Pickering, Oliver Lung, Finlay Maguire, Peter Kruczkiewicz, Jonathon D. Kotwa, Tore Buchanan, et al. (+34)
25 [GO] 2022―Oct―26 Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial Manish C. Choudhary, Kara W. Chew, Rinki Deo, James P. Flynn, James Regan, Charles R. Crain, et al. (+52)
26 [GO] 2022―Oct―26 Evasion of cGAS and TRIM5 defines pandemic HIV Lorena Zuliani-Alvarez, Morten L. Govasli, Jane Rasaiyaah, Chris Monit, Stephen O. Perry, Rebecca P. Sumner, et al. (+12)
27 [GO] 2022―Oct―26 Capsid adaptation defines pandemic HIV
28 [GO] 2022―Oct―04 SARS-CoV-2 Omicron variant emerged under immune selection Chee Wah Tan, Wan Ni Chia, Feng Zhu, Barnaby E. Young, Napaporn Chantasrisawad, Shi-Hsia Hwa, et al. (+17)
29 [GO] 2022―Sep―23 SARS-CoV-2 Delta and Omicron variants evade population antibody response by mutations in a single spike epitope Ping He, Banghui Liu, Xijie Gao, Qihong Yan, Rongjuan Pei, Jing Sun, et al. (+27)
30 [GO] 2022―Sep―16 Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway Brian J. Willett, Joe Grove, Oscar A. MacLean, Craig Wilkie, Giuditta De Lorenzo, Wilhelm Furnon, et al. (+686)
31 [GO] 2022―Aug―18 Genomic epidemiology of the SARS-CoV-2 epidemic in Brazil Marta Giovanetti, Svetoslav Nanev Slavov, Vagner Fonseca, Eduan Wilkinson, Houriiyah Tegally, José Salvatore Leister Patané, et al. (+97)
32 [GO] 2022―Aug―02 COVID-19-associated fungal infections Martin Hoenigl, Danila Seidel, Rosanne Sprute, Cristina Cunha, Matteo Oliverio, Gustavo H. Goldman, et al. (+2)
33 [GO] 2022―Jul―25 Patient-derived monoclonal antibody neutralizes SARS-CoV-2 Omicron variants and confers full protection in monkeys Craig Fenwick, Priscilla Turelli, Dongchun Ni, Laurent Perez, Kelvin Lau, Cécile Herate, et al. (+20)
34 [GO] 2022―Jul―18 Early detection and surveillance of SARS-CoV-2 genomic variants in wastewater using COJAC Katharina Jahn, David Dreifuss, Ivan Topolsky, Anina Kull, Pravin Ganesanandamoorthy, Xavier Fernandez-Cassi, et al. (+18)
35 [GO] 2022―Jul―14 Neutralizing antibody activity against 21 SARS-CoV-2 variants in older adults vaccinated with BNT162b2 Joseph Newman, Nazia Thakur, Thomas P. Peacock, Dagmara Bialy, Ahmed M. E. Elrefaey, Carlijn Bogaardt, et al. (+10)
36 [GO] 2022―Jul―12 Omicron: a shift in the biology of SARS-CoV-2
37 [GO] 2022―Jul―07 SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway Brian J. Willett, Joe Grove, Oscar A. MacLean, Craig Wilkie, Giuditta De Lorenzo, Wilhelm Furnon, et al. (+686)
38 [GO] 2022―Jun―30 Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2 Xiaoyu Sun, Chunyan Yi, Yuanfei Zhu, Longfei Ding, Shuai Xia, Xingchen Chen, et al. (+32)
39 [GO] 2022―Jun―15 Therapeutic efficacy of monoclonal antibodies and antivirals against SARS-CoV-2 Omicron BA.1 in Syrian hamsters Ryuta Uraki, Maki Kiso, Masaki Imai, Seiya Yamayoshi, Mutsumi Ito, Seiichiro Fujisaki, et al. (+9)
40 [GO] 2022―Jun―09 Inactivated whole-virion vaccine BBV152/Covaxin elicits robust cellular immune memory to SARS-CoV-2 and variants of concern Rajesh Vikkurthi, Asgar Ansari, Anupama R. Pai, Someshwar Nath Jha, Shilpa Sachan, Suvechchha Pandit, et al. (+21)
41 [GO] 2022―May―30 Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia Anupriya Aggarwal, Alberto Ospina Stella, Gregory Walker, Anouschka Akerman, Camille Esneau, Vanessa Milogiannakis, et al. (+36)
42 [GO] 2022―May―23 Author Correction: Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile Mónica L. Acevedo, Aracelly Gaete-Argel, Luis Alonso-Palomares, Marco Montes de Oca, Andrés Bustamante, Aldo Gaggero, et al. (+10)
43 [GO] 2022―May―05 Postdoctoral life in a pandemic Ann C. Gregory
44 [GO] 2022―Apr―28 Daily longitudinal sampling of SARS-CoV-2 infection reveals substantial heterogeneity in infectiousness Ruian Ke, Pamela P. Martinez, Rebecca L. Smith, Laura L. Gibson, Agha Mirza, Madison Conte, et al. (+33)
45 [GO] 2022―Apr―28 SARS-CoV-2-specific T-cell epitope repertoire in convalescent and mRNA-vaccinated individuals Julia Lang-Meli, Hendrik Luxenburger, Katharina Wild, Vivien Karl, Valerie Oberhardt, Elahe Salimi Alizei, et al. (+21)
46 [GO] 2022―Apr―27 An orally available Mpro inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron Bao-Xue Quan, Huiping Shuai, An-Jie Xia, Yuxin Hou, Rui Zeng, Xin-Lei Liu, et al. (+22)
47 [GO] 2022―Apr―01 Differential neutralizing antibody responses elicited by CoronaVac and BNT162b2 against SARS-CoV-2 Lambda in Chile Mónica L. Acevedo, Aracelly Gaete-Argel, Luis Alonso-Palomares, Marco Montes de Oca, Andrés Bustamante, Aldo Gaggero, et al. (+10)
48 [GO] 2022―Feb―07 Longitudinal analysis of antibody dynamics in COVID-19 convalescents reveals neutralizing responses up to 16 months after infection Yang Yang, Minghui Yang, Yun Peng, Yanhua Liang, Jinli Wei, Li Xing, et al. (+11)
49 [GO] 2022―Feb―07 Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario Sharifa Nasreen, Hannah Chung, Siyi He, Kevin A. Brown, Jonathan B. Gubbay, Sarah A. Buchan, et al. (+10)
50 [GO] 2022―Jan―11 Increased small particle aerosol transmission of B.1.1.7 compared with SARS-CoV-2 lineage A in vivo Julia R. Port, Claude Kwe Yinda, Victoria A. Avanzato, Jonathan E. Schulz, Myndi G. Holbrook, Neeltje van Doremalen, et al. (+3)
51 [GO] 2022―Jan―10 Induction of robust cellular and humoral immunity against SARS-CoV-2 after a third dose of BNT162b2 vaccine in previously unresponsive older adults Addi J. Romero-Olmedo, Axel Ronald Schulz, Svenja Hochstätter, Dennis Das Gupta, Iiris Virta, Heike Hirseland, et al. (+11)
52 [GO] 2022―Jan―10 Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California Venice Servellita, Mary Kate Morris, Alicia Sotomayor-Gonzalez, Amelia S. Gliwa, Erika Torres, Noah Brazer, et al. (+22)
53 [GO] 2021―Dec―31 Nowcasting the spread of SARS-CoV-2 Hagai Rossman, Eran Segal
54 [GO] 2021―Dec―31 Improving local prevalence estimates of SARS-CoV-2 infections using a causal debiasing framework George Nicholson, Brieuc Lehmann, Tullia Padellini, Koen B. Pouwels, Radka Jersakova, James Lomax, et al. (+6)
55 [GO] 2021―Dec―14 Synthetic DNA spike-ins (SDSIs) enable sample tracking and detection of inter-sample contamination in SARS-CoV-2 sequencing workflows Kim A. Lagerborg, Erica Normandin, Matthew R. Bauer, Gordon Adams, Katherine Figueroa, Christine Loreth, et al. (+18)
56 [GO] 2021―Oct―22 Children primed and ready for SARS-CoV-2 Emily Speranza
57 [GO] 2021―Oct―15 Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern Liane Dupont, Luke B. Snell, Carl Graham, Jeffrey Seow, Blair Merrick, Thomas Lechmere, et al. (+26)
58 [GO] 2021―Sep―27 Lung microbiota and COVID-19 severity Robert P. Dickson
59 [GO] 2021―Sep―21 Genetic and structural basis for SARS-CoV-2 variant neutralization by a two-antibody cocktail Jinhui Dong, Seth J. Zost, Allison J. Greaney, Tyler N. Starr, Adam S. Dingens, Elaine C. Chen, et al. (+26)
60 [GO] 2021―Sep―08 Genomics, social media and mobile phone data enable mapping of SARS-CoV-2 lineages to inform health policy in Bangladesh Lauren A. Cowley, Mokibul Hassan Afrad, Sadia Isfat Ara Rahman, Md Mahfuz Al Mamun, Taylor Chin, Ayesha Mahmud, et al. (+16)
61 [GO] 2021―Sep―01 Cellular host factors for SARS-CoV-2 infection Jim Baggen, Els Vanstreels, Sander Jansen, Dirk Daelemans
62 [GO] 2021―Aug―31 Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome Imran Sulaiman, Matthew Chung, Luis Angel, Jun-Chieh J. Tsay, Benjamin G. Wu, Stephen T. Yeung, et al. (+46)
63 [GO] 2021―Aug―16 SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution Jiří Zahradník, Shir Marciano, Maya Shemesh, Eyal Zoler, Daniel Harari, Jeanne Chiaravalli, et al. (+12)
64 [GO] 2021―Jul―21 Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom Jia Wei, Nicole Stoesser, Philippa C. Matthews, Daniel Ayoubkhani, Ruth Studley, Iain Bell, et al. (+64)
65 [GO] 2021―Jun―30 How SARS-CoV-2 makes the cut Markus Hoffmann, Stefan Pöhlmann
66 [GO] 2021―Jun―23 Emergence and spread of a SARS-CoV-2 lineage A variant (A.23.1) with altered spike protein in Uganda Daniel Lule Bugembe, My V. T. Phan, Isaac Ssewanyana, Patrick Semanda, Hellen Nansumba, Beatrice Dhaala, et al. (+5)
67 [GO] 2021―Jun―09 SARS-CoV-2 Variants of Interest and Concern naming scheme conducive for global discourse Frank Konings, Mark D. Perkins, Jens H. Kuhn, Mark J. Pallen, Erik J. Alm, Brett N. Archer, et al. (+41)
68 [GO] 2021―Apr―27 The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets Thomas P. Peacock, Daniel H. Goldhill, Jie Zhou, Laury Baillon, Rebecca Frise, Olivia C. Swann, et al. (+14)
69 [GO] 2021―Mar―16 ISG15-dependent activation of the sensor MDA5 is antagonized by the SARS-CoV-2 papain-like protease to evade host innate immunity GuanQun Liu, Jung-Hyun Lee, Zachary M. Parker, Dhiraj Acharya, Jessica J. Chiang, Michiel van Gent, et al. (+5)
70 [GO] 2021―Jan―29 Addendum: A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology Andrew Rambaut, Edward C. Holmes, Áine O’Toole, Verity Hill, John T. McCrone, Christopher Ruis, et al. (+2)
71 [GO] 2021―Jan―27 Author Correction: Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland Ana da Silva Filipe, James G. Shepherd, Thomas Williams, Joseph Hughes, Elihu Aranday-Cortes, Patawee Asamaphan, et al. (+46)
72 [GO] 2021―Jan―18 Publisher Correction: Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland Ana da Silva Filipe, James G. Shepherd, Thomas Williams, Joseph Hughes, Elihu Aranday-Cortes, Patawee Asamaphan, et al. (+46)
73 [GO] 2021―Jan―18 Author Correction: Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets Dhiraj Kumar Singh, Bindu Singh, Shashank R. Ganatra, Michal Gazi, Journey Cole, Rajesh Thippeshappa, et al. (+56)
74 [GO] 2020―Dec―21 Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into Scotland Ana da Silva Filipe, James G. Shepherd, Thomas Williams, Joseph Hughes, Elihu Aranday-Cortes, Patawee Asamaphan, et al. (+46)
75 [GO] 2020―Dec―21 The SARS-CoV-2 RNA-protein interactome in infected human cells Nora Schmidt, Caleb A. Lareau, Hasmik Keshishian, Sabina Ganskih, Cornelius Schneider, Thomas Hennig, et al. (+15)
76 [GO] 2020―Dec―18 Responses to acute infection with SARS-CoV-2 in the lungs of rhesus macaques, baboons and marmosets Dhiraj Kumar Singh, Bindu Singh, Shashank R. Ganatra, Michal Gazi, Journey Cole, Rajesh Thippeshappa, et al. (+56)
77 [GO] 2020―Dec―03 Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets Robert M. Cox, Josef D. Wolf, Richard K. Plemper
78 [GO] 2020―Nov―16 Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals Jian Zhang, Qian Wu, Ziyan Liu, Qijie Wang, Jiajing Wu, Yabin Hu, et al. (+28)
79 [GO] 2020―Nov―02 How to establish an academic SARS-CoV-2 testing laboratory Alex Richter, Tim Plant, Michael Kidd, Andrew Bosworth, Megan Mayhew, Oliver Megram, et al. (+7)
80 [GO] 2020―Oct―26 Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans Jeffrey Seow, Carl Graham, Blair Merrick, Sam Acors, Suzanne Pickering, Kathryn J. A. Steel, et al. (+36)
81 [GO] 2020―Oct―21 Language matters in a pandemic
82 [GO] 2020―Oct―07 Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters Shuofeng Yuan, Runming Wang, Jasper Fuk-Woo Chan, Anna Jinxia Zhang, Tianfan Cheng, Kenn Ka-Heng Chik, et al. (+8)
83 [GO] 2020―Sep―10 Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies Wen Shi Lee, Adam K. Wheatley, Stephen J. Kent, Brandon J. DeKosky
84 [GO] 2020―Jul―28 Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic Maciej F. Boni, Philippe Lemey, Xiaowei Jiang, Tommy Tsan-Yuk Lam, Blair W. Perry, Todd A. Castoe, et al. (+2)
85 [GO] 2020―Jul―24 Research funding after COVID-19 Miguel Prudêncio, Joana C. Costa
86 [GO] 2020―Jul―23 LY6E impairs coronavirus fusion and confers immune control of viral disease Stephanie Pfaender, Katrina B. Mar, Eleftherios Michailidis, Annika Kratzel, Ian N. Boys, Philip V’kovski, et al. (+21)
87 [GO] 2020―Jul―15 A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology Andrew Rambaut, Edward C. Holmes, Áine O’Toole, Verity Hill, John T. McCrone, Christopher Ruis, et al. (+2)
88 [GO] 2020―Jul―10 Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT-qPCR primer-probe sets Chantal B. F. Vogels, Anderson F. Brito, Anne L. Wyllie, Joseph R. Fauver, Isabel M. Ott, Chaney C. Kalinich, et al. (+39)
89 [GO] 2020―May―20 Antimicrobial resistance in the age of COVID-19
90 [GO] 2020―Apr―07 SARS-CoV-2 detection in patients with influenza-like illness Wen-Hua Kong, Yao Li, Ming-Wei Peng, De-Guang Kong, Xiao-Bing Yang, Leyi Wang, Man-Qing Liu
91 [GO] 2020―Mar―02 The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
92 [GO] 2020―Feb―24 Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses Michael Letko, Andrea Marzi, Vincent Munster
 [1] 

92 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.039 sec